These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24135816)

  • 21. FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.
    Wynes MW; Hinz TK; Gao D; Martini M; Marek LA; Ware KE; Edwards MG; Böhm D; Perner S; Helfrich BA; Dziadziuszko R; Jassem J; Wojtylak S; Sejda A; Gozgit JM; Bunn PA; Camidge DR; Tan AC; Hirsch FR; Heasley LE
    Clin Cancer Res; 2014 Jun; 20(12):3299-309. PubMed ID: 24771645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer.
    Zhang L; Yu H; Badzio A; Boyle TA; Schildhaus HU; Lu X; Dziadziuszko R; Jassem J; Varella-Garcia M; Heasley LE; Kowalewski AA; Ellison K; Chen G; Zhou C; Hirsch FR
    J Thorac Oncol; 2015 Jul; 10(7):1083-90. PubMed ID: 26020126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic implications of
    Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
    World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer.
    Elakad O; Lois AM; Schmitz K; Yao S; Hugo S; Lukat L; Hinterthaner M; Danner BC; von Hammerstein-Equord A; Reuter-Jessen K; Schildhaus HU; Ströbel P; Bohnenberger H
    Cancer Med; 2020 May; 9(10):3574-3583. PubMed ID: 32207251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.
    André F; Bachelot T; Campone M; Dalenc F; Perez-Garcia JM; Hurvitz SA; Turner N; Rugo H; Smith JW; Deudon S; Shi M; Zhang Y; Kay A; Porta DG; Yovine A; Baselga J
    Clin Cancer Res; 2013 Jul; 19(13):3693-702. PubMed ID: 23658459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models.
    Zhang J; Zhang L; Su X; Li M; Xie L; Malchers F; Fan S; Yin X; Xu Y; Liu K; Dong Z; Zhu G; Qian Z; Tang L; Schöttle J; Zhan P; Ji Q; Kilgour E; Smith PD; Brooks AN; Thomas RK; Gavine PR
    Clin Cancer Res; 2012 Dec; 18(24):6658-67. PubMed ID: 23082000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target.
    Lee MJ; Kim N; Choung HK; Choe JY; Khwarg SI; Kim JE
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):125-33. PubMed ID: 26141290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue Sarcoma.
    Chudasama P; Renner M; Straub M; Mughal SS; Hutter B; Kosaloglu Z; Schweßinger R; Scheffler M; Alldinger I; Schimmack S; Persigehl T; Kobe C; Jäger D; von Kalle C; Schirmacher P; Beckhaus MK; Wolf S; Heining C; Gröschel S; Wolf J; Brors B; Weichert W; Glimm H; Scholl C; Mechtersheimer G; Specht K; Fröhling S
    Clin Cancer Res; 2017 Feb; 23(4):962-973. PubMed ID: 27535980
    [No Abstract]   [Full Text] [Related]  

  • 29. Functional characterization, localization, and inhibitor sensitivity of the TPR-FGFR1 fusion in 8p11 myeloproliferative syndrome.
    Malli T; Buxhofer-Ausch V; Rammer M; Erdel M; Kranewitter W; Rumpold H; Marschon R; Deutschbauer S; Simonitsch-Klupp I; Valent P; Muellner-Ammer K; Sebesta C; Birkner T; Webersinke G
    Genes Chromosomes Cancer; 2016 Jan; 55(1):60-8. PubMed ID: 26391436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
    Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
    Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic implications of Fibroblast growth factor receptor 1 (FGFR1) gene amplification and protein overexpression in hypopharyngeal and laryngeal squamous cell carcinoma.
    Kim EK; Cho YA; Koh YW; Shin HA; Cho BC; Yoon SO
    BMC Cancer; 2020 Apr; 20(1):348. PubMed ID: 32326908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancer.
    Schröck A; Göke F; Wagner P; Bode M; Franzen A; Huss S; Agaimy A; Ihrler S; Kirsten R; Kristiansen G; Bootz F; Lengerke C; Perner S
    Head Neck; 2014 Sep; 36(9):1253-7. PubMed ID: 23913758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma.
    Weeden CE; Holik AZ; Young RJ; Ma SB; Garnier JM; Fox SB; Antippa P; Irving LB; Steinfort DP; Wright GM; Russell PA; Ritchie ME; Burns CJ; Solomon B; Asselin-Labat ML
    Mol Cancer Ther; 2017 Aug; 16(8):1610-1622. PubMed ID: 28611104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma.
    von Loga K; Kohlhaussen J; Burkhardt L; Simon R; Steurer S; Burdak-Rothkamm S; Jacobsen F; Sauter G; Krech T
    PLoS One; 2015; 10(11):e0141867. PubMed ID: 26555375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting FGFR with BGJ398 in Breast Cancer: Effect on Tumor Growth and Metastasis.
    Sahores A; May M; Sequeira GR; Fuentes C; Jacobsen B; Lanari C; Lamb CA
    Curr Cancer Drug Targets; 2018; 18(10):979-987. PubMed ID: 29237381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
    Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
    Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of the fibroblast growth factor receptor inhibitors dovitinib (TKI258) and NVP-BGJ398 in human endometrial cancer cells.
    Konecny GE; Kolarova T; O'Brien NA; Winterhoff B; Yang G; Qi J; Qi Z; Venkatesan N; Ayala R; Luo T; Finn RS; Kristof J; Galderisi C; Porta DG; Anderson L; Shi MM; Yovine A; Slamon DJ
    Mol Cancer Ther; 2013 May; 12(5):632-42. PubMed ID: 23443805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FGFR1 signaling potentiates tumor growth and predicts poor prognosis in esophageal squamous cell carcinoma patients.
    Chen B; Liu S; Gan L; Wang J; Hu B; Xu H; Tong R; Yang H; Cristina I; Xue J; Hu X; Lu Y
    Cancer Biol Ther; 2018 Jan; 19(1):76-86. PubMed ID: 29257923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets.
    Lee HJ; Seo AN; Park SY; Kim JY; Park JY; Yu JH; Ahn JH; Gong G
    Ann Surg Oncol; 2014 May; 21(5):1561-8. PubMed ID: 24385208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FGFR1 Amplification in Squamous Cell Carcinoma of the Lung with Correlation of Primary and Metastatic Tumor Status.
    Monaco SE; Rodriguez EF; Mahaffey AL; Dacic S
    Am J Clin Pathol; 2016 Jan; 145(1):55-61. PubMed ID: 26712871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.